G

Garvan Institute of Medical Research

Genetic disease-focused biomedical research institute

IT Support Specialist

Full-TimePosted on 10/22/2026
$85k+ Superannuation + Salary packaging
Mid
Sydney NSW, Australia
In PersonOnsite in the office 5 days per week initially.
IT OperationsIT Service Desk & End User Support

About the job

Requirements
  • Two to four years of help desk experience or experience in a similar environment, including experience with a ticketing system.
  • Experience supporting laptops running macOS and Windows 11, including Office 365.
  • Ability to multitask and work quickly under pressure.
  • Flexibility, reliability, strong research and troubleshooting ability, good time management, attention to detail, and ability to work unsupervised.
  • A strong customer service ethic and focus on providing a high level of service.
Responsibilities
  • Provide first- and second-level technical support to more than 700 users by telephone, service desk portal, and in person.
  • Staff daily IT Bar shifts from 9–11 a.m. and 2–4 p.m. to provide walk-up IT support to Garvan Building staff.
  • Wipe and rebuild laptops according to standard operating procedures as part of asset management duties.
  • Support macOS and Windows devices and Microsoft products such as Office 365.
  • Maintain printers and other peripheral equipment.
  • Set up, maintain, and support Mac and Windows workstations and laptops.
  • Provide technical expertise and act as a central point of contact for technology users, resolving requests in a timely and efficient manner while projecting a positive, client-focused image.
  • Record, update, and maintain detailed information in the help desk ticketing database.
  • Support technology-related equipment and hardware, IP telephony systems, audio-visual equipment, photocopiers, and scanners.
  • Maintain a high level of customer satisfaction within the business.

About the company

G

Garvan Institute of Medical Research

View

Garvan Institute of Medical Research conducts biomedical research to understand how genes, molecules, and cells influence health and disease, aiming to prevent and treat major illnesses. It combines fundamental science with strong clinical collaborations to translate discoveries into medical advances. What sets Garvan apart is its sustained, long-term work that integrates laboratory research with direct clinical interactions across a range of diseases, not just one specialty. Its goal is to prevent, treat, or cure major diseases such as cancer, diabetes/obesity, neurological disorders, osteoporosis, and immunological diseases by uncovering mechanisms and developing new therapies.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Sydney, Australia

Founded

1963

Get referred to Garvan Institute of Medical Research

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • NHMRC awarded Garvan’s autoimmune centre funding on 7 September 2026, extending five-year support.
  • Garvan secured NHMRC funding boosts on 10 August 2026 for genomic and immune discoveries.
  • Garvan announced new cancer labs and recruitment in August 2026, signaling continued scientific expansion.

What critics are saying

  • Garvan’s revenue depends on grants and philanthropy; one funding gap can freeze programs quickly.
  • Revelio shows 663 employees in March 2026 and only 16 postings, signaling hiring caution.
  • If translational bets like PatientSeek or CAR-T fail, Garvan remains a research-only cost center.

What makes Garvan Institute of Medical Research unique

  • Garvan’s autoimmune CRE under Chris Goodnow targets somatic mutation biology, not generic immunology.
  • Its Genomics Platform joined Parse Biosciences in July 2026, expanding regional single-cell access.
  • Garvan pairs discovery research with clinical trial networks, including Parkinson’s stratification and cancer studies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Parental Leave
  • Flexible Work Hours
  • Professional Development Budget
  • Conference Attendance Budget
  • Employee Discounts

Company News

BioSpace
Feb 22nd, 2023
C4Xd And Garvan Institute Of Medical Research Report Successful Patient Stratification Approach Using C4Xd'S New Precision Medicine Platform Patientseek

First validation of C4XD's patient sub-groups through a Garvan-led retrospective clinical trial analysis. Promising initial result paves way for novel approaches in Parkinson's disease stratification. Launch of PatientSeek platform enables stratification of patients to identify the right patient for the right medicine